Dextrose And Sodium Chloride Injection, Solution
Product Images NDC 63323-867

9 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dextrose And Sodium Chloride (NDC 63323-867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexsod-img-01.jpg (Dexsod Img 01)

FDA Label Image

Dexsod-struc-01.jpg (Dexsod Struc 01)

Dexsod-struc-01.jpg (Dexsod Struc 01)
Chemical structure diagram showing Dextrose Monohydrate, illustrating its molecular arrangement including a glucose ring with hydroxyl groups and a water molecule (H2O) associated.*
FDA Label Image

Dexsod-img-02.jpg (Dexsod Img 02)

FDA Label Image

Dexsod-label-01.jpg (Dexsod Label 01)

Dexsod-label-01.jpg (Dexsod Label 01)
Label for 250 mL injection solution of Dextrose and Sodium Chloride USP, containing 5% Dextrose and 0.3% Sodium Chloride. The label indicates intravenous use with detailed ingredient amounts per 100 mL: Dextrose Hydrous 5 g and Sodium Chloride 300 mg. Manufactured by Fresenius Kabi USA, LLC, located in Lake Zurich, IL, and made in Germany.*
FDA Label Image

Dexsod-label-02.jpg (Dexsod Label 02)

Dexsod-label-02.jpg (Dexsod Label 02)
Label for 5% Dextrose and 0.3% Sodium Chloride Injection, USP, 250 mL vial pack of 30, manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions and barcode, with product and manufacturer details, indicating intravenous solution form.*
FDA Label Image

Dexsod-label-03.jpg (Dexsod Label 03)

Dexsod-label-03.jpg (Dexsod Label 03)
Label for 5% Dextrose and 0.3% Sodium Chloride Injection, USP, 500 mL intravenous solution by Fresenius Kabi USA, LLC. It lists contents per 100 mL: 5 g dextrose and 300 mg sodium chloride, provides usage instructions, storage conditions (20° to 25°C), and notes the container type and manufacturing details including origin (Germany).*
FDA Label Image

Dexsod-label-04.jpg (Dexsod Label 04)

Dexsod-label-04.jpg (Dexsod Label 04)
Label for 5% Dextrose and 0.3% Sodium Chloride Injection, USP, 500 mL, manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions between 20° to 25°C and protection from freezing, along with the NDC 63323-867 and a barcode. The product is made in Germany and intended for intravenous use.*
FDA Label Image

Dexsod-label-05.jpg (Dexsod Label 05)

Dexsod-label-05.jpg (Dexsod Label 05)
Label for Dextrose and Sodium Chloride Injection, USP, 5% Dextrose and 0.3% Sodium Chloride in 1000 mL intravenous solution. The label includes drug content per 100 mL, storage instructions at 20° to 25°C, and manufacturer details for Fresenius Kabi USA, LLC, made in Germany. Barcode and lot/expiration fields are also visible.*
FDA Label Image

Dexsod-label-06.jpg (Dexsod Label 06)

Dexsod-label-06.jpg (Dexsod Label 06)
Label for 5% Dextrose and 0.3% Sodium Chloride Injection, USP, 1,000 mL in a carton of 10. The injectable solution is manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, and made in Germany. Storage instructions specify 20° to 25°C (68° to 77°F) and protection from freezing. The label includes barcode, lot, and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.